Cited by 176Peroxisome Proliferator-Activated ReceptorsFatty Acid Research and HealthParaoxonase enzyme and polymorphisms

Covalent Peroxisome Proliferator-activated Receptor γ Adduction by Nitro-fatty Acids

Open access
Schopfer, Francisco J., Cole, Marsha P., Groeger, Alison L., Chen, Chen-Shan, Khoo, Nicholas K.H., Woodcock, Steven R., Golin-Bisello, Franca, Motanya, U.Nkiru +12 more·2010·Journal of Biological Chemistry

Abstract

The peroxisome proliferator-activated receptor-gamma (PPARgamma) binds diverse ligands to transcriptionally regulate metabolism and inflammation. Activators of PPARgamma include lipids and anti-hyperglycemic drugs such as thiazolidinediones (TZDs). Recently, TZDs have raised concern after being linked with increased risk of peripheral edema, weight gain, and adverse cardiovascular events. Most reported endogenous PPARgamma ligands are intermediates of lipid metabolism and oxidation that bind PPARgamma with very low affinity. In contrast, nitro derivatives of unsaturated fatty acids (NO(2)-FA) are endogenous products of nitric oxide ((*)NO) and nitrite (NO(2)(-))-mediated redox reactions that activate PPARgamma at nanomolar concentrations. We report that NO(2)-FA act as partial agonists of PPARgamma and covalently bind PPARgamma at Cys-285 via Michael addition. NO(2)-FA show selective PPARgamma modulator characteristics by inducing coregulator protein interactions, PPARgamma-dependent expression of key target genes, and lipid accumulation is distinctively different from responses induced by the TZD rosiglitazone. Administration of this class of signaling mediators to ob/ob mice revealed that NO(2)-FA lower insulin and glucose levels without inducing adverse side effects such as the increased weight gain induced by TZDs.

Integrity signals

Registry

Crossref · 10.1074/jbc.m109.091512

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In murine models of metabolic syndrome, fatty acid nitroalkene administration at nanomolar concentrations limits weight gain and loss of insulin sensitivity.

    “Thus, in murine models of metabolic and inflammatory injury, fatty acid nitroalkene administration at nanomolar concentrations prevents restenosis after vessel injury (49), limits weight gain and loss of insulin sensitivity in murine models of metabolic syndrome (14), protects against ischemia-reperfusion injury (17,47,50), reduces plaque formation in a rodent model of atherosclerosis (51), and in”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schopfer, F. J., Cole, M. P., Groeger, A. L., Chen, C.-S., Khoo, N. K. H., Woodcock, S. R., Golin-Bisello, F., Motanya, U. N., Li, Y., Zhang, J., Garcia-Barrio, M. T., Rudolph, T. K., Rudolph, V., Bonacci, G., Baker, P. R. S., Xu, H. E., Batthyany, C. I., Chen, Y. E., Hallis, T. M., & Freeman, B. A.
Affiliations
  • University of Pittsburgh (US)
  • Van Andel Institute (US)
  • University of Michigan (US)
  • Morehouse School of Medicine (US)
  • Universität Hamburg (DE)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2010-04
Volume
285
Issue
16
Pages
12321-12333
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2010571219
Cited by
171
References
44
Citations by year
2026: 4 · 2025: 10 · 2024: 8 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 12 · 2019: 15 · 2018: 13 · 2017: 9 · 2016: 11 · 2015: 18 · 2014: 12 · 2013: 15 · 2012: 10
FWCI
6.12
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p30dk046204-15)
  • National Heart, Lung, and Blood Institute (R01HL64937, R01HL064937, R01HL089544, R01HL089301, R37HL058115, R01HL058115, HL68878, R01HL068878, K99HL095769, R01-HL-58115, R01HL075397, HL089544, HL089301, HL-75397)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK066202, P30 DK 046204-15, DK066202, DK071662, R01DK071662, T32DK007052, P30-DK046204)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords
PPARγ, nitro-fatty acids, Michael addition, thiazolidinediones, rosiglitazone, PPARγ partial agonists, nitric oxide, nitrite, lipid accumulation, ob/ob mice, weight gain
MeSH terms
Rosiglitazone, Amino Acid Sequence, Animals, Base Sequence, Blood Glucose, Cell Line, Diabetes Mellitus, Fatty Acids, Unsaturated, Humans, Hypoglycemic Agents, Insulin, Ligands, Male, Mice, Inbred C57BL, Mice, Obese, Molecular Sequence Data, Nitro Compounds, Protein Binding, Protein Processing, Post-Translational, Recombinant Proteins, Signal Transduction, Mutagenesis, Site-Directed, Protein Structure, Tertiary, DNA Primers, Oleic Acid, Amino Acid Substitution, 3T3-L1 Cells, Thiazolidinediones, PPAR gamma, Lipid Metabolism, Mice, Tandem Mass Spectrometry, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review